Triple

T22717594
Position Surface form Disambiguated ID Type / Status
Subject Genzyme E561775 entity
Predicate hasProduct P3585 FINISHED
Object Lemtrada
Lemtrada is a monoclonal antibody medication used primarily to treat relapsing forms of multiple sclerosis by targeting immune cells.
 E1550580 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Lemtrada | Statement: [Genzyme, hasProduct, Lemtrada]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Lemtrada
Context triple: [Genzyme, hasProduct, Lemtrada]
  • A. Tysabri
    Tysabri is a monoclonal antibody medication primarily used to treat relapsing forms of multiple sclerosis and Crohn’s disease.
  • B. Tecfidera
    Tecfidera is an oral disease-modifying medication used to treat relapsing forms of multiple sclerosis by reducing inflammation and relapse frequency.
  • C. Cosentyx
    Cosentyx is a biologic medication (secukinumab) used to treat autoimmune inflammatory conditions such as psoriasis, psoriatic arthritis, and ankylosing spondylitis.
  • D. Taltz
    Taltz is a prescription biologic medication (ixekizumab) used to treat moderate to severe plaque psoriasis and certain types of arthritis by targeting the inflammatory protein IL-17A.
  • E. Stelara
    Stelara is a prescription biologic medication (ustekinumab) used to treat autoimmune conditions such as psoriasis, psoriatic arthritis, and Crohn’s disease by targeting specific immune system pathways.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Lemtrada
Triple: [Genzyme, hasProduct, Lemtrada]
Generated description
Lemtrada is a monoclonal antibody medication used primarily to treat relapsing forms of multiple sclerosis by targeting immune cells.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: Lemtrada
Target entity description: Lemtrada is a monoclonal antibody medication used primarily to treat relapsing forms of multiple sclerosis by targeting immune cells.
  • A. Tysabri
    Tysabri is a monoclonal antibody medication primarily used to treat relapsing forms of multiple sclerosis and Crohn’s disease.
  • B. Tecfidera
    Tecfidera is an oral disease-modifying medication used to treat relapsing forms of multiple sclerosis by reducing inflammation and relapse frequency.
  • C. Cosentyx
    Cosentyx is a biologic medication (secukinumab) used to treat autoimmune inflammatory conditions such as psoriasis, psoriatic arthritis, and ankylosing spondylitis.
  • D. Taltz
    Taltz is a prescription biologic medication (ixekizumab) used to treat moderate to severe plaque psoriasis and certain types of arthritis by targeting the inflammatory protein IL-17A.
  • E. Stelara
    Stelara is a prescription biologic medication (ustekinumab) used to treat autoimmune conditions such as psoriasis, psoriatic arthritis, and Crohn’s disease by targeting specific immune system pathways.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e2454fc984819088213b58ee87a002 completed April 17, 2026, 2:35 p.m.
NER Named-entity recognition batch_69f1790ecbc48190926d16b20b674dbd completed April 29, 2026, 3:20 a.m.
NED1 Entity disambiguation (via context triple) batch_6a0b7edf9c988190ba19b094f3232c87 completed May 18, 2026, 9:04 p.m.
NEDg Description generation batch_6a0b8076dd848190b7ee7c745ddee3c5 completed May 18, 2026, 9:11 p.m.
NED2 Entity disambiguation (via description) batch_6a0b819ebe90819088593ffcd70251b1 completed May 18, 2026, 9:16 p.m.
Created at: April 17, 2026, 3:19 p.m.